Skip to content

Clinical trials

Phase 1 Ovarian Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1 Country / region: Taiwan Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20162
20171
20181
20191
20202
20211
20222
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Acepodia Biotech, Inc.1
Alterome Therapeutics, Inc.1
Arcus Biosciences, Inc.1
Astellas Pharma Global Development, Inc.1
EMD Serono Research & Development Institute, Inc.1
Eli Lilly and Company1
Impact Therapeutics, Inc.1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms16
Carcinoma, Non-Small-Cell Lung10
Neoplasms8
Stomach Neoplasms7
Esophageal Neoplasms6
Pancreatic Neoplasms6
Squamous Cell Carcinoma of Head and Neck6
Breast Neoplasms5
Colorectal Neoplasms5
Endometrial Neoplasms5

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.